Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
2.650
-0.250 (-8.62%)
Dec 27, 2024, 4:00 PM EST
Interpace Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 4.7 | 0.8 | -21.96 | -14.94 | -26.45 | -26.74 | Upgrade
|
| Depreciation & Amortization | 0.72 | 1.6 | 3.5 | 5.37 | 5.5 | 4.52 | Upgrade
|
| Other Amortization | - | 0.04 | 0.06 | 0.12 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.07 | 0.06 | - | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 12.4 | - | 0.04 | - | Upgrade
|
| Stock-Based Compensation | 0.35 | 0.63 | 1.3 | 1.37 | 2.24 | 1.54 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.1 | - | - | -0.14 | 0.59 | 0.5 | Upgrade
|
| Other Operating Activities | 0.78 | 0.8 | 1.07 | 0.57 | -1.12 | 3.61 | Upgrade
|
| Change in Accounts Receivable | -2.49 | 0.05 | -0.13 | 2.15 | 1.73 | -1.1 | Upgrade
|
| Change in Accounts Payable | 0.4 | 0.49 | -0.74 | -1.82 | -0.2 | -0.94 | Upgrade
|
| Change in Other Net Operating Assets | 0.21 | -0.62 | -3.12 | -1.46 | 3.7 | -0.37 | Upgrade
|
| Operating Cash Flow | 4.6 | 3.79 | -7.69 | -8.72 | -13.98 | -18.96 | Upgrade
|
| Capital Expenditures | -0.89 | -0.47 | -0.32 | -0.35 | -1.58 | -0.13 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.04 | - | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -13.83 | Upgrade
|
| Other Investing Activities | - | 0.38 | 6.53 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.89 | -0.09 | 6.21 | -0.32 | -1.58 | -13.95 | Upgrade
|
| Short-Term Debt Issued | - | - | 2 | 7.5 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 1 | 9.5 | - | 3 | Upgrade
|
| Total Debt Issued | - | - | 3 | 17 | - | 3 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -7.92 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.5 | - | - | -3 | -6.02 | Upgrade
|
| Total Debt Repaid | -4.1 | -2.5 | - | -7.92 | -3 | -6.02 | Upgrade
|
| Net Debt Issued (Repaid) | -4.1 | -2.5 | 3 | 9.08 | -3 | -3.02 | Upgrade
|
| Issuance of Common Stock | - | - | 0.11 | 0.34 | 0.43 | 6.48 | Upgrade
|
| Repurchase of Common Stock | -0.03 | -0.03 | -0.11 | - | -0.05 | -0.04 | Upgrade
|
| Other Financing Activities | -2.5 | -2.5 | - | -0.44 | - | - | Upgrade
|
| Financing Cash Flow | -6.63 | -5.03 | 3 | 8.98 | 16.61 | 29.16 | Upgrade
|
| Net Cash Flow | -2.92 | -1.33 | 1.51 | -0.06 | 1.05 | -3.75 | Upgrade
|
| Free Cash Flow | 3.71 | 3.32 | -8.01 | -9.07 | -15.55 | -19.09 | Upgrade
|
| Free Cash Flow Margin | 8.27% | 8.25% | -25.17% | -27.40% | -48.01% | -78.81% | Upgrade
|
| Free Cash Flow Per Share | 0.84 | 0.76 | -1.89 | -2.19 | -3.86 | -5.10 | Upgrade
|
| Cash Interest Paid | 1.09 | 1.09 | 0.97 | 0.42 | 0.06 | 0.17 | Upgrade
|
| Cash Income Tax Paid | 0.27 | 0.27 | 0.25 | 0.37 | 0.22 | 0.23 | Upgrade
|
| Levered Free Cash Flow | 1.94 | 4.22 | -0.03 | 1.78 | -5.08 | -4.55 | Upgrade
|
| Unlevered Free Cash Flow | 2.43 | 4.81 | 0.54 | 2.31 | -4.74 | -4.28 | Upgrade
|
| Change in Net Working Capital | 1.73 | -1.29 | 1.55 | 0.25 | -4.08 | -4.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.